# Suzhou Juwei Yuanchuang Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/suzhou-juwei-yuanchuang-biotechnology

- Industry: Biotechnology
- Headquarters: Suzhou, China
- Latest round: Series A (Oct 3, 2022)
- Investors on record: 6

## About

Established in 2018 and based in Suzhou, China, Suzhou Juwei Yuanchuang Biotechnology is a biotechnology company that focuses on the biotransformation and utilization of non-food producing materials. The company's CTO, Dr. Seung Lee, graduated from the Massachusetts Institute of Technology. In April 2025, it closed a pre-series B4 funding from new investors Lan Fund, and Jiangsu Coast Development Group.

The company's main business is the sales of biological and animal feed and feed additives, technical services in the field of breeding, and comprehensive utilization of crop straw. The company self-developed bioconversion and utilization technologies of non-food biomass are used in the preparation of various biological products such as material-based materials, fine chemicals, animal nutrition products, and industrial enzymes.

The company generates revenue by developing bioconversion and utilization of non-food biomass, converting agricultural and livestock waste into fermentation feedstock.

## Funding rounds

- Series A, Oct 3, 2022 — CMB International Asset Management, GF Xinde Investment, HosenCare Brothers
- Angel, Aug 13, 2019 — Tsing-Yuan Capital, Taiyou Fund, TusSeed

## Investors

- Tsing-Yuan Capital (https://capitalatlas.ai/funds/tsing-yuan-capital) — Angel
- Taiyou Fund — Angel
- TusSeed — Angel
- CMB International Asset Management (https://capitalatlas.ai/funds/cmb-international-asset-management) — Series A
- GF Xinde Investment (https://capitalatlas.ai/funds/gf-xinde-investment) — Series A
- HosenCare Brothers (https://capitalatlas.ai/funds/hosencare-brothers) — Series A